World Health Organization Removes ‘Gender Identity Disorder’ Diagnosis in New Health Guidelines Recognizing Transgender Rights 27/05/2019 Editorial team (Human Rights Watch) – The World Health Organization (WHO) approved a major change to its global manual of diagnoses on May 25, 2019, that will greatly benefit transgender people around the world, Human Rights Watch said today. The World Health Assembly, the WHO governing body that represents 194 member states, voted for new diagnostic guidelines […] Continue reading -> Medicine Prices: Secrecy Of R&D Costs Remains Issue In Near-Final World Health Assembly Resolution 26/05/2019 Elaine Ruth Fletcher The latest working draft World Health Assembly resolution calling for game-changing public disclosure of the prices paid for medicines, vaccines and other health products by countries and health systems shows a broad coalition of countries from Europe, Latin America, Africa and Asia forming around the compromise draft. The draft, obtained Sunday by Health Policy Watch, […] Continue reading -> US-Venezuela Tensions Simmer At World Health Assembly, While Global Community Scales Up Emergency Medical Aid 26/05/2019 John Zarocostas Mounting political tensions between the United States and the embattled Venezuelan government of President Nicolás Maduro, including a proliferation of crippling US sanctions, are being played out in the halls of the 72nd World Health Assembly, marred by walkouts and finger-pointing by the two adversaries. Image Credits: WHO/PAHO, John Zarocostas. Continue reading -> Medicine Prices – Delegates Near Agreement On Softer Resolution For Disclosure 26/05/2019 Elaine Ruth Fletcher After a grueling 34 hours of nearly non-stop negotiations, World Health Assembly delegates appeared to be close to a final agreement Saturday evening on a resolution supporting more systematic disclosure of prices for medicines purchased and sold on national and global markets; a “drafting group” is expected to reconvene Monday morning to put the finishing […] Continue reading -> Snakebite Envenoming: WHO Launches First-Ever Strategy For Prevention & Control 24/05/2019 Catherine Saez The World Health Organization today launched its first-ever global strategy for the prevention and control of snakebite envenoming, just one year after the World Health Assembly agreed on a resolution to fight this neglected cause of death and disability. Image Credits: Catherine Saez. Continue reading -> Little Progress Over Price Transparency Resolution; Negotiators Behind Closed Doors 24/05/2019 Catherine Saez Secrecy was the watchword Friday as countries huddled together behind closed doors trying to reach agreement on a WHA resolution that would shed more sunshine on the real prices of medicines in national and global pharmaceutical markets. Image Credits: Max Pixel, Catherine Saez. Continue reading -> Price Transparency In Medicines Markets – Scrutinizing Evidence Behind The Claims 24/05/2019 Editorial team As the debate over a draft resolution supporting greater price transparency for medicines in national and global markets intensifies, with closed-door consultations among countries at the 72nd World Health Assembly continuing late into the night, Health Policy Watch continues to feature diverse “Inside Views” on this charged issue. Here, Suerie Moon, MPA PhD, faculty member […] Continue reading -> Behind The Headlines: How Can Industry Contribute To Cancer Care As Part Of Universal Health Coverage? 24/05/2019 Elaine Ruth Fletcher From preventive screening to the quality of nursing care and the structure of national insurance systems, patients face multiple barriers to cancer prevention, treatment and care, said a high-level panel of experts at a side event on the margins of this week’s World Health Assembly (20-28 May). Image Credits: UnternehmerTUM/@birdyfoto.de. Continue reading -> Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise […] Continue reading -> Five Billion People Still At Risk From Industrial Trans Fat Exposure 23/05/2019 Elaine Ruth Fletcher Some 28 WHO member states, representing 31 percent of the global population, have moved to restrict or ban the use of health-harmful industrial trans fats (TFAs) in food products – but that leaves two-thirds of the world’s population still exposed to risks from TFAs that kill approximately half a million people a year. Image Credits: […] Continue reading -> Posts navigation Older postsNewer posts
Medicine Prices: Secrecy Of R&D Costs Remains Issue In Near-Final World Health Assembly Resolution 26/05/2019 Elaine Ruth Fletcher The latest working draft World Health Assembly resolution calling for game-changing public disclosure of the prices paid for medicines, vaccines and other health products by countries and health systems shows a broad coalition of countries from Europe, Latin America, Africa and Asia forming around the compromise draft. The draft, obtained Sunday by Health Policy Watch, […] Continue reading -> US-Venezuela Tensions Simmer At World Health Assembly, While Global Community Scales Up Emergency Medical Aid 26/05/2019 John Zarocostas Mounting political tensions between the United States and the embattled Venezuelan government of President Nicolás Maduro, including a proliferation of crippling US sanctions, are being played out in the halls of the 72nd World Health Assembly, marred by walkouts and finger-pointing by the two adversaries. Image Credits: WHO/PAHO, John Zarocostas. Continue reading -> Medicine Prices – Delegates Near Agreement On Softer Resolution For Disclosure 26/05/2019 Elaine Ruth Fletcher After a grueling 34 hours of nearly non-stop negotiations, World Health Assembly delegates appeared to be close to a final agreement Saturday evening on a resolution supporting more systematic disclosure of prices for medicines purchased and sold on national and global markets; a “drafting group” is expected to reconvene Monday morning to put the finishing […] Continue reading -> Snakebite Envenoming: WHO Launches First-Ever Strategy For Prevention & Control 24/05/2019 Catherine Saez The World Health Organization today launched its first-ever global strategy for the prevention and control of snakebite envenoming, just one year after the World Health Assembly agreed on a resolution to fight this neglected cause of death and disability. Image Credits: Catherine Saez. Continue reading -> Little Progress Over Price Transparency Resolution; Negotiators Behind Closed Doors 24/05/2019 Catherine Saez Secrecy was the watchword Friday as countries huddled together behind closed doors trying to reach agreement on a WHA resolution that would shed more sunshine on the real prices of medicines in national and global pharmaceutical markets. Image Credits: Max Pixel, Catherine Saez. Continue reading -> Price Transparency In Medicines Markets – Scrutinizing Evidence Behind The Claims 24/05/2019 Editorial team As the debate over a draft resolution supporting greater price transparency for medicines in national and global markets intensifies, with closed-door consultations among countries at the 72nd World Health Assembly continuing late into the night, Health Policy Watch continues to feature diverse “Inside Views” on this charged issue. Here, Suerie Moon, MPA PhD, faculty member […] Continue reading -> Behind The Headlines: How Can Industry Contribute To Cancer Care As Part Of Universal Health Coverage? 24/05/2019 Elaine Ruth Fletcher From preventive screening to the quality of nursing care and the structure of national insurance systems, patients face multiple barriers to cancer prevention, treatment and care, said a high-level panel of experts at a side event on the margins of this week’s World Health Assembly (20-28 May). Image Credits: UnternehmerTUM/@birdyfoto.de. Continue reading -> Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise […] Continue reading -> Five Billion People Still At Risk From Industrial Trans Fat Exposure 23/05/2019 Elaine Ruth Fletcher Some 28 WHO member states, representing 31 percent of the global population, have moved to restrict or ban the use of health-harmful industrial trans fats (TFAs) in food products – but that leaves two-thirds of the world’s population still exposed to risks from TFAs that kill approximately half a million people a year. Image Credits: […] Continue reading -> Posts navigation Older postsNewer posts
US-Venezuela Tensions Simmer At World Health Assembly, While Global Community Scales Up Emergency Medical Aid 26/05/2019 John Zarocostas Mounting political tensions between the United States and the embattled Venezuelan government of President Nicolás Maduro, including a proliferation of crippling US sanctions, are being played out in the halls of the 72nd World Health Assembly, marred by walkouts and finger-pointing by the two adversaries. Image Credits: WHO/PAHO, John Zarocostas. Continue reading -> Medicine Prices – Delegates Near Agreement On Softer Resolution For Disclosure 26/05/2019 Elaine Ruth Fletcher After a grueling 34 hours of nearly non-stop negotiations, World Health Assembly delegates appeared to be close to a final agreement Saturday evening on a resolution supporting more systematic disclosure of prices for medicines purchased and sold on national and global markets; a “drafting group” is expected to reconvene Monday morning to put the finishing […] Continue reading -> Snakebite Envenoming: WHO Launches First-Ever Strategy For Prevention & Control 24/05/2019 Catherine Saez The World Health Organization today launched its first-ever global strategy for the prevention and control of snakebite envenoming, just one year after the World Health Assembly agreed on a resolution to fight this neglected cause of death and disability. Image Credits: Catherine Saez. Continue reading -> Little Progress Over Price Transparency Resolution; Negotiators Behind Closed Doors 24/05/2019 Catherine Saez Secrecy was the watchword Friday as countries huddled together behind closed doors trying to reach agreement on a WHA resolution that would shed more sunshine on the real prices of medicines in national and global pharmaceutical markets. Image Credits: Max Pixel, Catherine Saez. Continue reading -> Price Transparency In Medicines Markets – Scrutinizing Evidence Behind The Claims 24/05/2019 Editorial team As the debate over a draft resolution supporting greater price transparency for medicines in national and global markets intensifies, with closed-door consultations among countries at the 72nd World Health Assembly continuing late into the night, Health Policy Watch continues to feature diverse “Inside Views” on this charged issue. Here, Suerie Moon, MPA PhD, faculty member […] Continue reading -> Behind The Headlines: How Can Industry Contribute To Cancer Care As Part Of Universal Health Coverage? 24/05/2019 Elaine Ruth Fletcher From preventive screening to the quality of nursing care and the structure of national insurance systems, patients face multiple barriers to cancer prevention, treatment and care, said a high-level panel of experts at a side event on the margins of this week’s World Health Assembly (20-28 May). Image Credits: UnternehmerTUM/@birdyfoto.de. Continue reading -> Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise […] Continue reading -> Five Billion People Still At Risk From Industrial Trans Fat Exposure 23/05/2019 Elaine Ruth Fletcher Some 28 WHO member states, representing 31 percent of the global population, have moved to restrict or ban the use of health-harmful industrial trans fats (TFAs) in food products – but that leaves two-thirds of the world’s population still exposed to risks from TFAs that kill approximately half a million people a year. Image Credits: […] Continue reading -> Posts navigation Older postsNewer posts
Medicine Prices – Delegates Near Agreement On Softer Resolution For Disclosure 26/05/2019 Elaine Ruth Fletcher After a grueling 34 hours of nearly non-stop negotiations, World Health Assembly delegates appeared to be close to a final agreement Saturday evening on a resolution supporting more systematic disclosure of prices for medicines purchased and sold on national and global markets; a “drafting group” is expected to reconvene Monday morning to put the finishing […] Continue reading -> Snakebite Envenoming: WHO Launches First-Ever Strategy For Prevention & Control 24/05/2019 Catherine Saez The World Health Organization today launched its first-ever global strategy for the prevention and control of snakebite envenoming, just one year after the World Health Assembly agreed on a resolution to fight this neglected cause of death and disability. Image Credits: Catherine Saez. Continue reading -> Little Progress Over Price Transparency Resolution; Negotiators Behind Closed Doors 24/05/2019 Catherine Saez Secrecy was the watchword Friday as countries huddled together behind closed doors trying to reach agreement on a WHA resolution that would shed more sunshine on the real prices of medicines in national and global pharmaceutical markets. Image Credits: Max Pixel, Catherine Saez. Continue reading -> Price Transparency In Medicines Markets – Scrutinizing Evidence Behind The Claims 24/05/2019 Editorial team As the debate over a draft resolution supporting greater price transparency for medicines in national and global markets intensifies, with closed-door consultations among countries at the 72nd World Health Assembly continuing late into the night, Health Policy Watch continues to feature diverse “Inside Views” on this charged issue. Here, Suerie Moon, MPA PhD, faculty member […] Continue reading -> Behind The Headlines: How Can Industry Contribute To Cancer Care As Part Of Universal Health Coverage? 24/05/2019 Elaine Ruth Fletcher From preventive screening to the quality of nursing care and the structure of national insurance systems, patients face multiple barriers to cancer prevention, treatment and care, said a high-level panel of experts at a side event on the margins of this week’s World Health Assembly (20-28 May). Image Credits: UnternehmerTUM/@birdyfoto.de. Continue reading -> Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise […] Continue reading -> Five Billion People Still At Risk From Industrial Trans Fat Exposure 23/05/2019 Elaine Ruth Fletcher Some 28 WHO member states, representing 31 percent of the global population, have moved to restrict or ban the use of health-harmful industrial trans fats (TFAs) in food products – but that leaves two-thirds of the world’s population still exposed to risks from TFAs that kill approximately half a million people a year. Image Credits: […] Continue reading -> Posts navigation Older postsNewer posts
Snakebite Envenoming: WHO Launches First-Ever Strategy For Prevention & Control 24/05/2019 Catherine Saez The World Health Organization today launched its first-ever global strategy for the prevention and control of snakebite envenoming, just one year after the World Health Assembly agreed on a resolution to fight this neglected cause of death and disability. Image Credits: Catherine Saez. Continue reading -> Little Progress Over Price Transparency Resolution; Negotiators Behind Closed Doors 24/05/2019 Catherine Saez Secrecy was the watchword Friday as countries huddled together behind closed doors trying to reach agreement on a WHA resolution that would shed more sunshine on the real prices of medicines in national and global pharmaceutical markets. Image Credits: Max Pixel, Catherine Saez. Continue reading -> Price Transparency In Medicines Markets – Scrutinizing Evidence Behind The Claims 24/05/2019 Editorial team As the debate over a draft resolution supporting greater price transparency for medicines in national and global markets intensifies, with closed-door consultations among countries at the 72nd World Health Assembly continuing late into the night, Health Policy Watch continues to feature diverse “Inside Views” on this charged issue. Here, Suerie Moon, MPA PhD, faculty member […] Continue reading -> Behind The Headlines: How Can Industry Contribute To Cancer Care As Part Of Universal Health Coverage? 24/05/2019 Elaine Ruth Fletcher From preventive screening to the quality of nursing care and the structure of national insurance systems, patients face multiple barriers to cancer prevention, treatment and care, said a high-level panel of experts at a side event on the margins of this week’s World Health Assembly (20-28 May). Image Credits: UnternehmerTUM/@birdyfoto.de. Continue reading -> Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise […] Continue reading -> Five Billion People Still At Risk From Industrial Trans Fat Exposure 23/05/2019 Elaine Ruth Fletcher Some 28 WHO member states, representing 31 percent of the global population, have moved to restrict or ban the use of health-harmful industrial trans fats (TFAs) in food products – but that leaves two-thirds of the world’s population still exposed to risks from TFAs that kill approximately half a million people a year. Image Credits: […] Continue reading -> Posts navigation Older postsNewer posts
Little Progress Over Price Transparency Resolution; Negotiators Behind Closed Doors 24/05/2019 Catherine Saez Secrecy was the watchword Friday as countries huddled together behind closed doors trying to reach agreement on a WHA resolution that would shed more sunshine on the real prices of medicines in national and global pharmaceutical markets. Image Credits: Max Pixel, Catherine Saez. Continue reading -> Price Transparency In Medicines Markets – Scrutinizing Evidence Behind The Claims 24/05/2019 Editorial team As the debate over a draft resolution supporting greater price transparency for medicines in national and global markets intensifies, with closed-door consultations among countries at the 72nd World Health Assembly continuing late into the night, Health Policy Watch continues to feature diverse “Inside Views” on this charged issue. Here, Suerie Moon, MPA PhD, faculty member […] Continue reading -> Behind The Headlines: How Can Industry Contribute To Cancer Care As Part Of Universal Health Coverage? 24/05/2019 Elaine Ruth Fletcher From preventive screening to the quality of nursing care and the structure of national insurance systems, patients face multiple barriers to cancer prevention, treatment and care, said a high-level panel of experts at a side event on the margins of this week’s World Health Assembly (20-28 May). Image Credits: UnternehmerTUM/@birdyfoto.de. Continue reading -> Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise […] Continue reading -> Five Billion People Still At Risk From Industrial Trans Fat Exposure 23/05/2019 Elaine Ruth Fletcher Some 28 WHO member states, representing 31 percent of the global population, have moved to restrict or ban the use of health-harmful industrial trans fats (TFAs) in food products – but that leaves two-thirds of the world’s population still exposed to risks from TFAs that kill approximately half a million people a year. Image Credits: […] Continue reading -> Posts navigation Older postsNewer posts
Price Transparency In Medicines Markets – Scrutinizing Evidence Behind The Claims 24/05/2019 Editorial team As the debate over a draft resolution supporting greater price transparency for medicines in national and global markets intensifies, with closed-door consultations among countries at the 72nd World Health Assembly continuing late into the night, Health Policy Watch continues to feature diverse “Inside Views” on this charged issue. Here, Suerie Moon, MPA PhD, faculty member […] Continue reading -> Behind The Headlines: How Can Industry Contribute To Cancer Care As Part Of Universal Health Coverage? 24/05/2019 Elaine Ruth Fletcher From preventive screening to the quality of nursing care and the structure of national insurance systems, patients face multiple barriers to cancer prevention, treatment and care, said a high-level panel of experts at a side event on the margins of this week’s World Health Assembly (20-28 May). Image Credits: UnternehmerTUM/@birdyfoto.de. Continue reading -> Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise […] Continue reading -> Five Billion People Still At Risk From Industrial Trans Fat Exposure 23/05/2019 Elaine Ruth Fletcher Some 28 WHO member states, representing 31 percent of the global population, have moved to restrict or ban the use of health-harmful industrial trans fats (TFAs) in food products – but that leaves two-thirds of the world’s population still exposed to risks from TFAs that kill approximately half a million people a year. Image Credits: […] Continue reading -> Posts navigation Older postsNewer posts
Behind The Headlines: How Can Industry Contribute To Cancer Care As Part Of Universal Health Coverage? 24/05/2019 Elaine Ruth Fletcher From preventive screening to the quality of nursing care and the structure of national insurance systems, patients face multiple barriers to cancer prevention, treatment and care, said a high-level panel of experts at a side event on the margins of this week’s World Health Assembly (20-28 May). Image Credits: UnternehmerTUM/@birdyfoto.de. Continue reading -> Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise […] Continue reading -> Five Billion People Still At Risk From Industrial Trans Fat Exposure 23/05/2019 Elaine Ruth Fletcher Some 28 WHO member states, representing 31 percent of the global population, have moved to restrict or ban the use of health-harmful industrial trans fats (TFAs) in food products – but that leaves two-thirds of the world’s population still exposed to risks from TFAs that kill approximately half a million people a year. Image Credits: […] Continue reading -> Posts navigation Older postsNewer posts
Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise […] Continue reading -> Five Billion People Still At Risk From Industrial Trans Fat Exposure 23/05/2019 Elaine Ruth Fletcher Some 28 WHO member states, representing 31 percent of the global population, have moved to restrict or ban the use of health-harmful industrial trans fats (TFAs) in food products – but that leaves two-thirds of the world’s population still exposed to risks from TFAs that kill approximately half a million people a year. Image Credits: […] Continue reading -> Posts navigation Older postsNewer posts
Five Billion People Still At Risk From Industrial Trans Fat Exposure 23/05/2019 Elaine Ruth Fletcher Some 28 WHO member states, representing 31 percent of the global population, have moved to restrict or ban the use of health-harmful industrial trans fats (TFAs) in food products – but that leaves two-thirds of the world’s population still exposed to risks from TFAs that kill approximately half a million people a year. Image Credits: […] Continue reading -> Posts navigation Older postsNewer posts